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Sir,
In order to address the public concern that the use of mobile
phones could increase the risk of brain tumours Schoemaker et al
have conducted a case–control study to assess the risk of acoustic
neuroma in relation to mobile phone use in 678 cases and 3553
controls. They concluded ‘there was no association of risk with the
duration of use, lifetime cumulative hours of use or number of
calls, for phone use overall, or for type of phone’. However, they
found an increased risk for tumour ipsilateral to the side most
used, for use of phone for 10 years or longer.
When addressing a public concern, the strength of evidence for
harmlessness is as relevant as evidence for harm. The study by
Schoemaker et al (2005) fails to present this.
The quality of the exposure data for the study was entirely
dependent on the accuracy of recall by subjects for up to and over
10 years, though this was not substantiated by reference to cross-
checking with billing data to determine the margins of error. The
accuracy of the recall of this data is crucial but not substantiated in
the paper. In fact, the authors refer to the study by Parslow et al,
which found substantial misclassification in recall data on mobile
phone use, but appear not to have not appreciated the significance
of this for Type 2 errors and their conclusions.
Parslow et al (2003) found only modest correlation between
recall data about mobile phone use from 93 volunteers and their
outgoing phone bills over a 6-month period, concluding that ‘self
reported mobile phone use may not fully represent patterns of
mobile phone use’. Similar findings were obtained by Samkange-
Zeeb et al (2004) and Shum et al (2005). These studies found
problems in recall data over relatively short periods of time, yet
Shoemaker et al, place reliance on recall for up to and over 10
years. Inaccurate data will cause substantial misclassification,
which will dilute any real effect on acoustic neuroma of cumulative
use or number of calls thereby increasing the likelihood of Type 2
error, and considerably diminishes the ability to offer genuine
reassurance to the public about the harmlessness of mobile
phones. This major limitation is not reflected in the conclusions or
abstract of the paper. By contrast the finding of increased acoustic
neuroma risk after 10 years of mobile phone use, depending
simply on recall of first use, is least likely to be erroneous (Type 1)
and is the better substantiated finding in their study.
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